1. Home
  2. ENOV vs OLMA Comparison

ENOV vs OLMA Comparison

Compare ENOV & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovis Corporation

ENOV

Enovis Corporation

N/A

Current Price

$20.88

Market Cap

1.0B

Sector

Industrials

ML Signal

N/A

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

N/A

Current Price

$7.06

Market Cap

949.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENOV
OLMA
Founded
1995
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
949.3M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
ENOV
OLMA
Price
$20.88
$7.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
12
Target Price
$36.08
★ $36.50
AVG Volume (30 Days)
1.3M
★ 1.3M
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 15.00
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.05
N/A
Revenue Next Year
$4.89
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.70
$6.24
52 Week High
$32.41
$36.26

Technical Indicators

Market Signals
Indicator
ENOV
OLMA
Relative Strength Index (RSI) 51.81 41.14
Support Level $19.14 $6.24
Resistance Level $27.20 $7.61
Average True Range (ATR) 1.01 0.49
MACD 0.16 0.13
Stochastic Oscillator 50.16 61.09

Price Performance

Historical Comparison
ENOV
OLMA

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: